StockStory.ai Logo
JN

JNJ

Johnson & Johnson

HealthcareDrug ManufacturersGrade: A-

The Story

Understanding Johnson & Johnson in simple terms

“
J&J is like a hospital's two best friends: the pharmacy that creates life-saving medicines and the medical supply store with cutting-edge tools.
”

Just like hospitals need both prescription drugs and medical equipment to treat patients, J&J provides both through its Innovative Medicine (pharmaceuticals) and MedTech (devices) segments. They've become the go-to supplier for the most critical healthcare needs.

Unlike simple suppliers, J&J invests billions in R&D to invent new treatments and devices, making them more like innovation labs than traditional vendors.

Understanding the Business

Johnson & Johnson develops and sells prescription medicines for serious diseases and medical devices used in hospitals and surgery.

$88.82B
Revenue
Shows the massive scale—they're one of the largest healthcare companies globally
$14.07B
Net Income
Strong profitability with about 16% profit margin, showing they can turn research investments into profits
138,100
Employees
Huge workforce indicates the complexity of drug development and global operations
They solve two main problems: creating medicines that treat complex diseases like cancer and arthritis, and making medical devices that help doctors perform surgeries and treat patients more effectively.
Hospitals, doctors, and insurance companies pay for their medical devices and equipment, while insurance companies (and some patients) pay for their prescription drugs.
J&J has a 137-year reputation for quality and safety, plus they invest heavily in research to create cutting-edge treatments that often work better than existing options—doctors trust their products for critical situations.
They spend billions on research to develop new drugs and medical devices, get regulatory approval, then sell them at high margins to recoup their investment—it's a high-risk, high-reward model where successful products can generate revenue for many years.
Moderately challenging—while you can grasp that they make drugs and medical devices, evaluating their pipeline of experimental drugs requires understanding complex science and regulatory processes. However, their long track record and diversified product portfolio make them more predictable than smaller biotech companies.

Quick Stats

A-
Financial Grade
Revenue
$88.82B
Net Income
$14.07B
Employees
138,100
Last updated: 3 months ago

Found This Helpful?

Share this analysis with your network or explore more AI-powered stock insights

Explore More Stocks

Stay Updated with AI-Powered Insights

Get weekly stock analysis and investment insights delivered to your inbox

No spam. Unsubscribe anytime.